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Abstract
The ability to create 3D tissues from induced pluripotent stem cells (iPSCs) is poised to revolutionize stem
cell research and regenerative medicine, including individualized, patient-specific stem cell-based treatments.
There are, however, few examples of tissue engineering using iPSCs. Their culture and differentiation is
predominantly planar for monolayer cell support or induction of self-organizing embryoids (EBs) and
organoids. Bioprinting iPSCs with advanced biomaterials promises to augment efforts to develop 3D tissues,
ideally comprising direct-write printing of cells for encapsulation, proliferation, and differentiation. Here, such
a method, employing a clinically amenable polysaccharide-based bioink, is described as the first example of
bioprinting human iPSCs for in situ expansion and sequential differentiation. Specifically, There are extrusion
printed the bioink including iPSCs, alginate (Al; 5% weight/volume [w/v]), carboxymethyl-chitosan (5% w/
v), and agarose (Ag; 1.5% w/v), crosslinked the bioink in calcium chloride for a stable and porous construct,
proliferated the iPSCs within the construct and differentiated the same iPSCs into either EBs comprising cells
of three germ lineages-endoderm, ectoderm, and mesoderm, or more homogeneous neural tissues containing
functional migrating neurons and neuroglia. This defined, scalable, and versatile platform is envisaged being
useful in iPSC research and translation for pharmaceuticals development and regenerative medicine.
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The ability to create three-dimensional (3D) tissues from induced pluripotent stem cells 
(iPSCs) is poised to revolutionize stem cell research and regenerative medicine, including 
individualized, patient-specific stem cell-based treatments. There are, however, few examples 
of tissue engineering using iPSCs. Their culture and differentiation is predominantly planar 
for monolayer cell support or induction of self-organizing embryoids (EBs) and organoids. 
Bioprinting iPSCs with advanced biomaterials promises to augment efforts to develop 3D 
tissues, ideally comprising direct-write printing of cells for encapsulation, proliferation, and 
differentiation. Here such a method, employing a clinically-amenable polysaccharide-based 
bioink, is described as the first example of bioprinting human iPSCs for in situ expansion and 
sequential differentiation. Specifically, we have extrusion printed the bioink including iPSCs, 
alginate (Al; 5% weight/volume [w/v]), carboxymethyl-chitosan (CMC; 5% w/v) and agarose 
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(Ag; 1.5% w/v), crosslinked the bioink in calcium chloride for a stable and porous construct, 
proliferated the iPSCs within the construct and differentiated the same iPSCs into either EBs 
comprising cells of three germ lineages – endoderm, ectoderm, and mesoderm, or more 
homogeneous neural tissues containing functional migrating neurons and neuroglia. This 
defined, scalable and versatile platform is envisaged being useful in iPSC research and 
translation for pharmaceuticals development and regenerative medicine. 
 
1. Introduction 
Human iPSCs, like embryonic stem cells, have the ability to self-renew for large-scale 
expansion whilst maintaining the capacity to differentiate to all cell types (~200) of the 
human body.[1-3] These qualities, together with the potential for autologous application, make 
iPSCs compelling candidates for cell replacement therapies, tissue and organ engineering, and 
pharmacology and toxicology screening.  
Since their discovery a decade ago, the development of culture protocols for human 
iPSCs has primarily focused on clinical-compliance,[4] cell line stability,[5] and efficiency of 
differentiation to desired cell lineages,[6] all the while retaining conventional monolayer (2D) 
culture. Recent interest in recapitulating the 3D cytoarchitecture of native tissues in vitro to 
better simulate cell behavior in vivo, together with advances in fabricating bioactive, 
mechanically tunable and biocompatible materials are driving the application of 3D 
configured biomaterials for stem cell research and therapy.[7, 8] For example, by mimicking 
important features of a target tissue including the extracellular microenvironment, 3D-
biomaterials have the potential to instruct cell fate and function in ways not previously 
attainable.[9] Therefore, although still exploratory, we envisage the synergism of stem-cell 
biology and 3D-biomaterial technology being influential in iPSC-based research and 
translation.  
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The small numbers of 3D systems for iPSC culture reported to date rely on the ability 
of iPSCs to self-organise when seeded onto or cast within supporting material such as 
conventional tumor-derived Matrigel® basement membrane or more defined polymeric 
scaffolds.[10-13] An alternative although previously untested approach to bioengineering 3D 
iPSC constructs is to apply advanced 3D bioprinting for direct-write (or co-) printing of stem 
cells together with biomaterial to reproducibly generate tissue of a desired architecture. Co-
printing represents a single-step approach to rapidly fabricate a 3D cellularized construct 
whereby iPSCs are immediately integrated with biomaterials by encapsulation for direct and 
complete contact with extracellular elements that more closely mimic the native cell 
microenvironment.  
Here we describe a body of work related to iPSC printing following on from our 
previously published report of human neural stem cell (NSC) printing.[14] By utilizing the 
defined clinically-amenable polysaccharide-based bioink containing Al, CMC and Ag, we 
have optimized extrusion printing of iPSCs (Figure 1A), enabling for the first time their 
maintenance as self-renewing stem cells within the printed construct after gelation. Cell 
proliferation endures for at least 9 days post-printing (Figure 1B) and stem cells can be 
uniquely differentiated in situ to self-assembling 3D cell aggregates called embryoid bodies 
with cells constituting all three primitive germ layers – mesoderm, ectoderm and endoderm 
(Figure 1C). Following transition of the printed iPSC constructs to neural 
induction/differentiation media, more homogeneous neural tissues can be generated with 
neurons and supporting neuroglia (Figure 1D). Neurons are active, form synapses, participate 
in network activity and show migratory behavior within a construct.  
Our findings affirm the efficacy of our previously described bioprinting platform for 
generating 3D tissues from human stem cells. Consistent with the biomaterials used providing 
a uniform bioink consistency and suitable viscosity (requiring an extrusion force of around 
8.5 N)14, cells can be printed for homogenous distribution and high viability, with support 
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sustained after ionic-crosslinking due to previously demonstrated mechanical properties 
including high gel porosity for permeability to bioactive factors, and stiffness  (indentation 
modulus < 5 kPa)14 for enduring biocompatibility. Having now adapted the platform for 
human iPSC printing and differentiation, we have verified its versatility for generating both 
neural and non-neural tissues including amenability to “notoriously difficult to culture” cell 
types such as human iPSCs.[15, 16]      
 
2. Results and Discussion 
2.1 iPSC bioprinting, survival and in situ proliferation  
Extrusion printing of optimal iPSC-laden bioink resulted in the generation of scaffolds 
containing uniformly distributed stem cells throughout (Figure 2A, B and C). Encapsulated 
cells were viable with negligible cell death apparent immediately after ink gelation by ionic-
crosslinking, persisting through extended culture in excess of 7 days (Figure 2A). iPSCs 
showed characteristic pluripotent cell morphology, similar to embryonic stem cells (ESCs), 
being round in shape with large nuclei and sparse cytoplasm. During the course of 
maintaining constructs for stem cell expansion, iPSCs proliferated to form aggregates of cells 
culminating in large spheroids by day 7. Spheroids could be clearly seen abutting the lumen 
of scaffolds and dispersed throughout the gel. The phenomenon of spheroid formation is 
consistent with colony formation during conventional 2D culture, but with spheroids 
reflecting well-defined clusters of tightly packed cells within a 3D system as compared to 
classical (2D) sharp-edged, flat, tightly packed colonies.[16]  
iPSC growth profiling showed cell proliferation increased from the time of printing 
and peaked at day 9 (Figure 2D). The observed peak and subsequent decrease is consistent 
with contact inhibition as cell cultures reach confluency within the constructs. Inhibition of 
cellular growth, division and motility is characteristic of mammalian cells when in close 
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contact with each other. Therefore, as iPSCs reached a high density by proliferating after 
printing, cessation of cell growth would reasonably be expected.  
Flow cytometry of iPSCs extracted from printed constructs after 10 days culture 
revealed ubiquitous expression of pluripotency cell markers OCT4, SOX2, TRA-1-60 and 
SSEA4, consistent with a persistent pluripotent stem cell state (Figure 2E; Figure S1, 
Supporting Information). Cell pluripotency was also confirmed by formation of prototypical 
iPSC-colonies from similarly extracted spheroids that were sub-cultured by conventional 2D-
planar method (Figure 2F). Moreover, immunophenotyping with confocal microscopy 
demonstrated iPSC-spheroids within constructs expressed OCT4, SOX2, SSEA4, and TRA-1-
60 (Figure 3).           
 
2.2 In situ differentiation of iPSCs to EBs comprising cells of three germ lineages – 
endoderm, ectoderm, and mesoderm  
The differentiation potential of printed constructs was initially investigated by directing 3D 
bioprinted iPSCs to form EBs within constructs. EBs are 3D cell aggregates, which mimic 
many of the hallmarks of embryonic development. As EBs develop, differentiated cell 
phenotypes of all three germ lineages arise.[17] Therefore, in addition to demonstrating multi-
lineage cell and tissue formation, the induction of EBs represents another test of pluripotency.   
EBs formed within 3D constructs following modification of the iPSC culture media to 
basic fibroblast growth factor (bFGF)-free medium 5 days post-printing. They displayed 
archetypal morphology, with radiating and retracting projections (Figure 4A; Video S1, 
Supporting Information). The observed projections are consistent with EBs often exhibiting 
tissue-like structures, such as the patterning of neurite extensions indicative of neuron 
organization.[18] Notwithstanding the evidence for neural cell lineage, assessment of gene 
expression of extracted EBs by reverse-transcription quantitative PCR (RT-qPCR) confirmed 
downregulation of pluripotency markers OCT4, NANOG, TDGF1, and UTF1 compared to 
  
6 
 
undifferentiated EB-controls, with increased expression of endodermal (H19 and PDX1), 
mesodermal (HAND1 and IGF2) and ectodermal (NES and TUBB-3) markers confirming 
iPSC differentiation to all germ lineages (Figure 4B and C). Taken together, these data 
substantiate the potential to form multiple cell and tissue types within and from the bioprinted 
constructs. Secondarily, the results are consistent with having maintained iPSC status for the 
period of preserving constructs in culture after printing, prior to differentiation.  
Interestingly, despite affirming pluripotency of undifferentiated iPSCs, and loss of 
pluripotency and multi-lineage cell induction with differentiation, it is notable that gene 
expression was not enhanced for every marker of differentiation in 3D bioprinted constructs 
compared to conventional 2D differentiation. Specifically, H19, Hand-1, NES and TUBB3 
were higher for printed constructs, but PDX1 and IGF2 were not. Modifying the properties of 
the bioink and parameters of printing and gelation could enable fine-tuning of a cohort of 
markers associated with a particular tissue lineage. However, the specific adjustments to 
method will depend on the cell types required, with desired (and potentially undesired) 
contemporaneous effects on initial stem cell support also needing to be considered. 
Accordingly, there may be a trade-off between iPSC support and differentiated cell and tissue 
support. Notwithstanding, and importantly, our current described protocol enables apposite 
stem cell support, measurable endodermal, ectodermal and mesodermal cell induction and 
support, while concomitantly affording robust neural cell and tissue induction and 
maintenance further described below. 
2.3 Directed differentiation of 3D bioprinted iPSC constructs to neural tissues 
While without specific medium supplements pluripotent stem cells have a tendency to 
differentiate to derivatives of the three germ lineages, alternative media compositions 
(including the use of defined growth factor additives) can promote differentiation toward one 
or another lineage.[6] Given our earlier work on generating neural tissues using bioprinted 
NSCs, we sought to similarly generate neural tissue from the 3D bioprinted iPSCs.  
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Differentiation involved an intermediate progenitor phase by culturing constructs in 
neural induction medium for 2-3 weeks from the third day after printing, followed by 
differentiation (using further modified medium including brain-derived neurotrophic factor; 
BDNF) into mature cells with phenotypes representative of different neuronal subtypes and 
supporting neuroglia. Consistent with forming iPSC-derived neural progenitors, 
immunophenotyping of constructs following 17 days of neural induction (20 days post-
printing) revealed cells expressing neural progenitor markers PAX6 and NESTIN (Figure 5). 
Subsequent analysis of further differentiated (> 30 days) constructs confirmed maturation to 
tissues comprising cells expressing pan-neuronal markers microtubule-associated protein 2 
(MAP2; Figure 6A and D) and class III beta-tubulin protein (TUBB3; Figure 6C), as well as 
radial glial and astrocyte marker glial fibrillary acid protein (GFAP; Figure 6B and D) and 
presynaptic vesicle glycoprotein synaptophysin (Figure 6C). MAP2-expressing neurons often 
abutted the neuroglia (Figure 6D) and synaptophysin colocalized to neurites and neuronal cell 
soma, including longer neurite projections between neuronal cell clusters (Figure 6C).  
Further immunocytochemistry together with RT-qPCR substantiated discrete neural 
cell subtypes including gamma-aminobutyric acid (GABA) expressing neurons (Figure 6E), 
corroborated by transcript for NKX2-1, as well as serotonergic marker PET1 and 
oligodendrocyte lineage transcription factor 2 (OLIG2) (Figure 7).  RT-qPCR also confirmed 
increased transcript for NES, TUBB3 and GFAP, with highest levels of expression for 3D 
differentiated iPSCs compared to undifferentiated controls and 2D differentiated iPSCs, as 
well as concomitant downregulation of pluripotency markers OCT4, NANOG, and SOX2 
(Figure 7). Finally, consistent with the presence of GABAergic neurons, neurons displayed 
recurrent increases in extracellular calcium concentration in response to GABA receptor-A 
antagonist bicuculline (Figure 8A; Video S2, Supporting Information). Functionality was also 
supported by neuronal cell migration within constructs, including characteristic long and 
dynamic leading processes (Figure 8B; Video S3, Supporting Information). Migrating 
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neurons generally exhibit a leading process, with some being branched and others single.[19] 
The example presently shown is a neuron with a “relatively unbranched process” that appears 
to retract and extend and a tip that clearly moves forward as the cell traverses the construct 
(Video S3, Supporting Information).   
Taken together, the above findings verify the ability to differentiate iPSCs within the 
bioprinted constructs and in particular their conversion to functional neural cells for 3D neural 
tissue formation. 
 
3. Conclusion    
There are a number of different yet-to-be-tested bioprinting platforms that may be 
suitable for 3D iPSC deposition including inkjet-based[20], laser-assisted[21] and electrospray[22, 
23] bioprinting. While it will be important to determine the utility of these platforms, our work 
represents the first example of bioprinting iPSCs for ensuing culture and expansion within a 
3D construct. In addition, we were able to sequentially differentiate printed iPSCs in situ to 
multiple lineages representative of all three germ layers – mesoderm, ectoderm and endoderm, 
as well as form more homogeneous neural tissues. To the best of our knowledge, the only 
other example of bioprinting pluripotent stem cells and more specifically iPSCs involved 
printing with cell culture media for subsequent immediate testing of post-printing cell 
viability and pluripotency.[24] The iPSCs were neither 3D-printed with supporting biomaterial, 
nor 3D-cultured or -differentiated following printing.  
We have overcome reputed difficulties with maintaining and differentiating iPSCs, in 
spite of printing, by using a bioink with well-characterised and inexpensive components, 
having optimal viscosity for initial cell support during printing, and continuing support after 
printing and gelation. Al, CMC and Ag are widely available and used for clinical purposes, 
each having inherent qualities beneficial to the bioprinting process and/or cell survival.[14, 25, 
26]  While we have previously detailed their individual and combined properties, briefly, Al 
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enabled cyotcompatible gelation using calcium chloride, CMC afforded favorable porosity 
and related permeability, and Ag provided the rheological properties required for printing.[14]  
Moreover, CMC has other known beneficial properties such as high moisture retention, low 
inflammatory, toxicity and antimicrobial responses, and promotion of cell adhesion, migration 
and proliferation.[27, 28]  
In summary, the ability to 3D print human iPSCs to then expand and generate cells of 
different lineages provides an unprecedented opportunity to form different, authentic and 
renewable body tissues. To this end, the present body of work represents a first important step, 
with further refinement of method expected to enhance tissue identity, architecture and 
function to better model development and diseases, for pharmaceuticals screening and 
assessing in vivo function and safety in animal models towards transplantation therapies.       
 
4. Experimental Section  
iPSC culture and differentiation: Working stocks of human iPSCs were maintained as 2D 
cultures in 5% CO2 at 37°C, mTeSR™1 (STEMCELL Technologies) on Matrigel® basement 
membrane matrix  (Corning) in 6-well plates (Greiner Bio-One). Cells were passaged when 
colony centres became dense by incubation with 0.02% disodium ethylenediamine 
tetraacetate (EDTA; Sigma-Aldrich) for 3 min and fluxing with a pipette, followed by a 1:4-
1:6 split. To form EBs, iPSC colonies were extracted non-enzymatically and transferred to 
fresh culture plates for non-adherent suspension culture in the medium without bFGF 
(Peprotech).  
For 3D printed hiPSC culture and differentiation, mTESR™1 was again used for 
hiPSC expansion, and medium (DMEM/F12, Life Technologies) supplemented with 20% 
KnockOut™ Serum Replacement (Life Technologies), 1×MEM non-essential amino acids 
solution (NEAA; 100x stock, Gibco) and 55 µM β-mercaptoethanol (Gibco) without bFGF 
was used for induction of EBs. For the former culture medium was supplemented with 5 µM 
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rock inhibitor Y-27632 (STEMCELL Technologies) for the first 3 days of culture, while for 
EB formation, medium was changed to bFGF-free medium on the fifth day post-printing.  
For 3D iPSC differentiation to neural lineage, neural induction medium (comprising 
DMEM/F12 (1:1; Gibco) supplemented with 1% N-2 supplement (Gibco), 2 µg/ml heparin 
(Sigma-Aldrich) and MEM NEAA was applied every 2 – 3 days from the third day after 
printing, and then 2-3 weeks later, the medium was changed to neuronal differentiation 
medium containing 2 parts DMEM F-12 : 1 part Neurobasal medium (Gibco) supplemented 
with 2% StemPro Neural Supplement (Gibco), 0.5 % N-2 Supplement and 50 ng/ml brain-
derived neurotrophic factor (BDNF; Peprotech) for 3 weeks culture.  
Bioink preparation and bioprinting: The bioink was prepared as previously described.[14] 
Briefly, agarose (Ag; Astral Scientific Pty Ltd) was dissolved in phosphate-buffered saline 
(PBS; pH7.4; Sigma-Aldrich) by heating in a microwave oven to give 1.5% (w/v), followed 
by addition of alginate (Al; MW ∼50,000 Da, M/G ratio of 1.67, viscosity of 100–300 cP for 
2 w/w solution, 25°C; Sigma-Aldrich) and carboxymethyl-chitosan (CMC; Shanghai DiBai 
Chemicals) to give 5% (w/v). After 1 hr stirring at 60 °C, the final solution was cooled to 
room temperature (RT) and 4x107 iPSCs were added per 0.5 ml bioink.  
Bioprinting was performed with a 3D-Bioplotter® System (EnvisionTEC) fitted with a 
55CC barrel (Nordson Australia) and 200 µm printing nozzle (Nordson Australia). Bioink 
samples were loaded into the barrel and centrifuged at 300 g at 15 oC for 1 min to remove air 
bubbles, followed by printing onto autoclaved glass slides. After printing, scaffolds were 
immersed in 2% (w/v) calcium chloride for 10 min to crosslink. After gelation, the constructs 
were rinsed 3 times in culture medium followed by 2 x 10 min washes and incubation in fresh 
culture medium for 1 h to remove excess calcium ions. 
Scanning Electron Microscopy (SEM): For SEM of printed constructs, samples were 
submersed in hiPSC culture media for 24 hr, freeze dried overnight using a Alpha 2-4 LD 
freeze dryer (Christ), then coated with 20 nm gold using a sputter coater (Edwards), and kept 
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desiccated until analysed.   SEM was performed using a JSM-7500FA LV Scanning Electron 
Microscope. For studies of internal structure, samples were fixed with 3.7% 
paraformaldehyde (PFA, Fluka) for 30 min, immersed in liquid nitrogen for 60 seconds, and 
then freeze-fractured using a cold razor blade. The fractured samples were immediately 
observed on the JSM-6490 LV Scanning Electron Microscope (Jeol).  
Live/dead iPSC analysis: Calcein AM (5 μg/ml, Life technologies) and propidium iodide (PI, 
5 μg/ml, Life technologies) were used to detect live and dead cells respectively. Briefly, 
constructs were incubated at 37 oC with Calcein AM for 10 min, followed by PI for 1 min. A 
Leica TSC SP5 II confocal microscope was used for image acquisition, with images from a 
minimum of five optical planes per construct merged (to capture the maximal projection of 
whole cell aggregates) for analysis using Fiji (Image J) software.[29] Three independent 
samples were evaluated for each gel composition. Depth coding of constructs was performed 
using the 3D Projection Tool in Leica Application Suite (LAS AF) software (Leica). 
Immunocytochemistry: Samples were fixed with 3.7 % paraformaldehyde (PFA) in PBS for 
30 min at RT. Samples were then blocked and permeabilized overnight with 5% (v/v) donkey 
serum (Merck Millipore) in PBS containing 0.3% (v/v) Triton X-100 (Sigma-Aldrich) at 4 °C. 
Samples were subsequently incubated with primary antibodies against OCT4 (mouse, 1:200, 
STEMCELL Technologies), SSEA4 (mouse, 1:200, STEMCELL Technologies), TRA-1-60 
(mouse, 1:200, STEMCELL Technologies), PAX6 (rabbit, 1:100, Sigma-Aldrich), nestin 
(mouse, 1:100; Invitrogen), synaptophysin (rabbit, 1:200; Merck Millipore), TUBB3 as 
recognised by the TuJ1 antibody (Chicken, 1:200, Merck Millipore) and GABA (rabbit, 
1:200; Sigma-Aldrich) or fluorescence conjugated antibodies GFAP (mouse, 1:100; Cell 
Signalling), MAP2 (mouse, 1:100, Merck Millipore), SOX2 (rabbit, 1:100; Cell Signalling) at 
4 °C overnight. On the second day, samples were rinsed with 0.1% Triton X-100 in PBS three 
times and samples with unconjugated primary antibody were incubated with species-specific 
Alexa Fluor tagged secondary antibody (1:1000; Invitrogen) for 1 hr at 37 °C. Nuclei were 
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labelled with 4',6-diamidino-2-phenylindole (DAPI, 10 μg/ml; Invitrogen) at RT for 10 min 
and Prolong Gold antifade reagent (Invitrogen) was employed to preserve fluorescence signal. 
Samples were mounted onto glass coverslips using Aquamount (ThermoScientific) and 
imaged with a Leica TSC SP5 II confocal microscope. Images were collected and analysed 
using Leica Application Suite AF (LAS AF) software (Leica). 
iPSC Proliferation Analysis: PrestoBlue™ (Invitrogen) cell viability reagent was used for 
iPSC proliferation studies, according to the manufacturer’s instructions. Briefly, at each time 
point measured, three cell-laden constructs were incubated with the reagent in culture medium 
for 1 hr at 37 oC. For each construct, 100 µl supernatant was transferred to a well of a 96-well 
plate and screened by a microplate reader (POLARstar Omega) to read fluorescence intensity. 
Constructs were subsequently rinsed in culture medium and returned to culture, with the 
process repeated for each time point until the study was completed.   
Real-time quantitative PCR (RT-qPCR): For RNA isolation, conventional 2D cultured iPSCs, 
EBs and neural cells were treated with TRIzol™ Reagent (Invitrogen). 3D gel-encapsulated 
cells were first treated with 0.05 M EDTA for 10 min, fluxed with a pipette,  followed by 
centrifugation at 600 g for 5 min. TRIzol™ Reagent was then used to isolate total RNA and 
isopropanol (Chem-Supply) was used to precipitate RNA. The purity and quantity of the RNA 
was assessed using a NanoDrop™ 2000c Spectrophotometer (Thermo Scientific). cDNA was 
synthesized from the RNA using random primers. A Gotaq 2-step RT-qPCR Kit (Promega) 
and Bio-Rad CFX Real Time PCR instrument were used to perform RT-qPCR. CFX software 
was used to analyse data according to delta-delta Ct method.[30] Primer sequence information 
is provided in Table S1 (Supporting Information). 
Flow cytometry: 3D gel-encapsulated iPSC-spheroids were extracted from the 3D structures 
as described above for RT-qPCR. For both extracted spheroids and 2D cultured iPSCs, cells 
were digested in 0.02% EDTA for 5 min and 10 min respectively, triturated, and passed 
through a 40 µm sieve to generate single cell preparations. After trituration, single cells were 
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pelleted followed by centrifugation at 300 g for 5 min and fixed with 3.7% paraformaldehyde 
solution in PBS on ice for 10 min. After 2 washes in 0.1% (v/v) Triton X-100 in PBS, cells 
were resuspended in blocking buffer (5% Goat Serum plus 0.3% Triton-x-100 in PBS) and 
placed on ice for 30 min. Cells were then incubated with primary antibodies for OCT4, 
SSEA4 and TRA-1-60 described above and SOX2 (rabbit, 1:200; STEMCELL 
Technologies), and diluted in wash buffer on ice for 30 min. Following a further 2-3 washes, 
species-specific secondary antibodies conjugated with Alexa Fluor (1:1000; Invitrogen) and 
diluted in blocking buffer were applied for 30 min on ice in the dark. Cells were then washed 
again before being resuspended in 2% FBS/PBS and analysed by a Accuri C6 flow cytometer 
(BD Biosciences). 
Calcium imaging: Calcium imaging was performed by incubating samples with 2 µM Fluo-4 
(Life Technologies) in fresh culture medium for 30 min at 37oC, followed by washing in 
Tyrode’s solution (5 mM KCl, 129mM NaCl, 2mM CaCl2, 1mM MgCl2, 30mM D-Glucose 
and 25 mM HEPES, pH 7.4).[31] The samples were mounted onto coverslips and observed on 
a Leica TSC SP5 II confocal microscope. The data were collected and quantified using LAS 
AF software (Leica). To induce intracellular calcium, GABA(A) receptor antagonist 
Bicuculline (50 µM; Sigma-Aldrich) was added with Tyrode’s solution for 3 min followed by 
further imaging. 
 
Supporting Information  
Supporting Information is available from the Wiley Online Library or from the author. 
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Figure 1. Schematic of the method for extrusion printing of iPSCs for 3D culture and 
differentiation. A) Bioink is prepared by suspending iPSCs with clinically-amenable 
polysaccharides Al (5% w/v), CMC (5% w/v) and Ag (1.5% w/v), followed by bioprinting 
and ionic-crosslinking for gelation. B) 3D iPSC-laden scaffolds are maintained in iPSC-
culture medium for stem cell proliferation/self-renewal within the printed construct. C) iPSCs 
can be differentiated in situ to self-assembling 3D EBs comprising cells of all three primitive 
germ layers – mesoderm, ectoderm and endoderm, or D) more homogeneous neural tissues 
using neural induction and differentiation media. Neural constructs incorporate functional 
(including migrating) neurons and supporting neuroglia. 
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Figure 2. Survival and proliferation of 3D bioprinted iPSCs, and cell sub-culture following 
extraction post-printing. A)  Live (Calcein AM) and dead (Propidium iodide; PI) iPSC 
staining within a printed construct at days 1, 3 and 7 post-printing. Initially encapsulated 
iPSCs are visible as evenly distributed single cells, with aggregates of cells increasingly 
apparent over time. By day 7 cell aggregates appear as large spheroids, abutting the lumen of 
scaffolds, though dispersed throughout the gel. B) Depth coding of iPSCs along the Z-axis of 
a 3D printed construct (0 – 476 µm).  C) SEM images of as-printed scaffold, inclusive of 
iPSCs. D) Time course of live (PrestoBlue cell viability indicator) iPSC content of gel 
constructs up to day 11 after printing (mean ± S.D.; n = 3). One-way ANOVA with 
Bonferroni post hoc test. *P < 0.0001 (day 7 vs day 1). E)  Flow cytometry of iPSCs extracted 
from 3D constructs 10 days post-printing and expressing Oct4, SOX2, TRA-1-60 and SSEA4 
(black histograms). Red histograms indicate the isotype controls. (See also Figure S1, 
Supporting Information). F) Following extraction of iPSC-spheroids from 3D printed 
constructs (ie. 11 days post-printing) they could be recovered for conventional planar sub-
culture forming classical iPSC-colonies on Matrigel® basement membrane matrix. Scale bars 
as indicated. 
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Figure 3. Immunophenotyping of 3D bioprinted human iPSCs 10 days post-printing. iPSCs 
formed spheroids, stained with DAPI, and expressed pluripotency markers A) OCT4, B) 
SOX2, C) SSEA4, and D) TRA-1-60. Pseudocoloured images as indicated by colour of text. 
Scale bars as indicated. 
 
 
Figure 4. In situ formation of EBs from 3D bioprinted human iPSCs 15 days post-printing 
(including 10 days iPSC differentiation). A) EBs formed within 3D constructs, displayed 
typical morphology, with elongated cell projections resembling neurite extensions radiating 
out and retracting over time (arrowheads; See also Video S1, Supporting Information). B) 
EBs within 3D constructs (arrowheads) were extracted for RT-qPCR. C) Comparative gene 
expression (OCT4, NANOG, TDGF1 and UTF1: pluripotency markers; H19 and PDX1: 
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endodermal markers; Hand-1 and IGF2: mesodermal markers; NES and TUBB3: ectodermal 
markers) between conventional 2D and 3D iPSCs and EBs. Relative gene expression 
represents data normalized to β-actin (ACTB) and expressed relative to 2D iPSCs. Mean ± 
S.D.; n  = 3. One-way Anova with Bonferroni post hoc test. *P< 0.05; ** P< 0.01; *** P< 
0.001. Scale bars as indicated.  
 
 
Figure 5. Immunophenotyping of 3D bioprinted human iPSCs 20 days post-printing 
including 17 days of neural induction. A) Cells stained with DAPI and expressed neural 
progenitor markers PAX6 and nestin.  B) Depth coding of cells along the Z-axis of a 3D 
printed construct (0 – 107 µm). Pseudocoloured images as indicated by colour of text. White 
dashed lines of DAPI and PAX6 labelling images outline the lumen of printed 
scaffold/construct. Scale bars as indicated.  
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Figure 6. Immunophenotyping of 3D bioprinted human iPSCs 40 days post-printing 
including 30-37 days of neural induction and differentiation. A) Cells stained with DAPI and 
expressed pan-neuronal marker MAP2 revealing neural processes extending throughout 
constructs, as well as B) radial glia and astrocyte marker GFAP. Also shown, depth coding of 
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cells along the Z-axis 0 – 63 µm and 0 – 56 µm respectively. C) Cells stained with DAPI and 
pan neuronal-marker TUBB3. Synaptophysin colocalized with TUBB3-labelled processes 
extending between neuronal cell clusters. D) MAP2 expressing neurons with neurites abutting 
and partially colocalized with GFAP expressing glial cells. E) GABAergic subtype neurons 
expressing GABA. Also, depth coding of cells along the Z-axis 0 – 47 µm. Pseudocoloured 
images as indicated by colour of text. Scale bars as indicated. 
 
 
Figure 7. Comparative gene expression (pluripotency: OCT4, NANOG, SOX2; neural: NES, 
TUBB3, GFAP, GABA, NKX2-1, PET1, OLIG2) between conventional 2D and 3D 
(bioprinted) hiPSC and neural derivative cultures. Mean ± S.D.; n  = 3. One-way Anova with 
Bonferroni post hoc test or Student’s t-test. *P< 0.05; ** P< 0.01; *** P< 0.001.  
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Figure 8. Live cell imaging of calcium flux and cell migration showing functional neurons 
forming networks within 3D structures 40 days after printing iPSCs including 37 days of 
neural induction and differentiation. A) Time course of bicuculline-induced calcium flux for 
individual neurons 1-2 within a 3D construct (arrowheads; See also Video S2, Supporting 
Information). The photomicrographs and corresponding line-plots show active cells 
(arrowheads) and average measurements of calcium flux respectively. Also shown, depth 
coding of cells along the Z-axis of the 3D printed construct (0 – 137 µm). B) Live cell 
imaging demonstrating neuronal cell migration within a 3D construct (large arrowheads: cell 
soma; small arrowheads: leading process).   (See also Video S3, Supporting Information). 
Pseudocoloured images as indicated by colour of text. Scale bars as indicated. 
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The table of contents entry: Human tissues are generated by 3D bioprinting human 
induced pluripotent stem cells that proliferate and differentiate to form renewable 3D 
tissues. 3D tissues comprise cells of the three germ lineages – endoderm, ectoderm and 
mesoderm, demonstrating the capacity to form all cells and tissues of the body, or more 
homogeneous neural tissues containing functional (including migrating) neurons and 
supporting neuroglia. 
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